Hangzhou Peptide Biochem Co.,Ltd

Zhejiang Paipeptide Biotechnology Co., Ltd. (ZPC) was established in July 2015. It has obtained a pharmaceutical production license and won the title of "National High-tech Enterprise". ZPC is located in Shaoxing High-tech Industrial Park with a registered capital of 20 million yuan. The first phase of the company covers an area of ​​13 acres and has a cGMP/FDA standard-compliant factory with an area of ​​more than 10,000 square meters. It has an annual output of 200KG of peptide APIs. The production capacity can meet the large-scale production of medicinal peptides. According to production needs, the second phase of the factory can be expanded to nearly 80 acres. The company currently has more than 200 employees, including more than 60 R&D personnel. It has obtained a number of invention patents and its products are sold at home and abroad. Hangzhou Paipeptide Biochemical Technology Co., Ltd. (HPC) was established in May 2014 and is wholly owned by the parent company, Zhejiang Paipeptide Biotechnology Co., Ltd. The R&D center is equipped with a GLP laboratory of 2,600 square meters in Xiasha Medical Port Town, Hangzhou, focusing on the development of peptide drugs. HPC is a high-tech biopharmaceutical R&D enterprise and a technology small and medium-sized enterprise that has been introduced by Hangzhou City. It has ISO9001-2008 quality system certification.